Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2007
11/20/2007US7297511 Interferon alpha: remodeling and glycoconjugation of interferon alpha
11/20/2007US7297493 Using fibroblast growth factor receptor activating gene 1 (FRAG1) probe as diagnostic tool in detection and classification of tumor disorders
11/20/2007US7297492 LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis
11/20/2007US7297489 Mutations in and genomic structure of HERG—a long QT syndrome gene
11/20/2007US7297487 Syrian hamster animal model for disease containing only the mutant desmin gene; Desmin gene of a Syrian hamster having a point mutation at the 571-position of the base sequence in the desmin cDNA translated region
11/20/2007US7297482 Structurally biased random peptide libraries based on different scaffolds
11/20/2007US7297340 containing a biofilm peptide, especially a Haemophilus influenzae biofilm peptide, used to prevent otitis media
11/20/2007US7297337 Ephrin-A2 lymphocyte receptor modulator for use in treatment and prevention of renal cell carcinoma; mimetics and antitumor agents
11/20/2007US7297333 For stimulating release of tumor necrosis factor and/or cell proliferation/differentiation of chondrocytes; induction of endothelial cell tube formation; cancer diagnosis
11/20/2007US7297099 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/20/2007CA2305810C Methods of assaying receptor activity and constructs useful in such methods
11/20/2007CA2262409C Modified tie-2-receptor ligands
11/20/2007CA2229544C Cyclic peptide analogs of somatostatin
11/20/2007CA2192455C Positive and positive/negative cell selection mediated by peptide release
11/20/2007CA1341561C Manufacture and expression of large structural genes
11/15/2007WO2007131133A2 Methods and compositions relating to zpa polypeptides
11/15/2007WO2007130638A2 Production of sialylated n-glycans in lower eukaryotes
11/15/2007WO2007130455A2 Compositions and methods for treatment of non-hodgkins lymphoma
11/15/2007WO2007130453A2 Non-natural amino acid substituted polypeptides
11/15/2007WO2007130302A2 Rage fusion proteins, formulations, and methods of use thereof
11/15/2007WO2007129218A2 Tpeptides for detecting or inducing production of antibodies against human papilloma virus, l1 protein or peptides from this protein.
11/15/2007WO2007129093A2 Hla peptide therapy
11/15/2007WO2007129091A1 Epigenetic regulatory complex for control of gene expression
11/15/2007WO2007129077A2 Imaging agent
11/15/2007WO2007129050A2 Method for production of cytochrome p450 with n-term. truncated p450 reductase
11/15/2007WO2007128979A1 Polypeptide antagonist
11/15/2007WO2007128838A1 Use of cells containing a specific dna molecule as cytopathic agents to inhibit the proliferation of cells
11/15/2007WO2007128815A1 Insulin derivative
11/15/2007WO2007128806A2 Methods for the in vitro screening of compounds inhibiting production of infectious hiv-1 virions
11/15/2007WO2007128796A1 Peptides for use in diagnosing the presence of ruptured atherosclerotic lesions in an individual
11/15/2007WO2007128755A2 P15 hairpin constructs and use
11/15/2007WO2007128563A1 Antibody-targeted cytokines for therapy
11/15/2007WO2007128554A2 Lipolytic enzymes
11/15/2007WO2007128545A2 Mac30 gene
11/15/2007WO2007128160A1 Cloning and expression of a novel phytase
11/15/2007WO2007128136A1 A novel pilin glycoprotein from a group 4 pseudomonas aeruginosa strain
11/15/2007WO2007128121A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same
11/15/2007WO2007128080A1 An assay for modulators of apoptosis
11/15/2007WO2007112377A9 Three-dimensional structure of hdhd4 complexed with magnesium and a phosphate mimetic
11/15/2007WO2007110001A3 Chimeric proteins comprising matrilin 1 for therapeutic use
11/15/2007WO2007107302A3 Novel genes encoding insecticidal proteins
11/15/2007WO2007106472A3 Non-mccj25-related lariat-peptide inhibitors of bacterial rna polymerase
11/15/2007WO2007101948A3 Novel vaccines for treating or preventing infections by parasites of the family taenidae and in particular of the genus echinococcus
11/15/2007WO2007088459A3 Transgenic animals defective for emilin protein with hypertensive phenotype
11/15/2007WO2007069249A3 Toxin-like polypeptides, polynucleotides encoding same and uses thereof
11/15/2007WO2007067682A3 In vivo cell surface engineering
11/15/2007WO2007066236A3 Chimeric hiv-1 gp120 glycoproteins and their biological applications
11/15/2007WO2007050798A3 Lrrtm1 compositions and methods of their use for the diagnosis and treatment of cancer
11/15/2007WO2007044751A3 Polynucleotides encoding phenylpropanoid pathway enzymes in coffee
11/15/2007WO2007014123A3 Compositions and methods of treating disease with fgfr fusion proteins
11/15/2007WO2007002018A3 Chimerac tbp-toxin proteins as mucosal adjuvants for vaccination against neisseriae
11/15/2007WO2006136162A3 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
11/15/2007WO2006122382A3 Composition comprising fractions or sub-fractions of leishmania promastigotes or leishmania amastigotes called fucose mannose ligand (fml) and saponin, composition for preparation of leishmaniasis transmission blocking vaccines in humans and animals comprising fractions or sub-fractions of leishmania promastigotes or leis
11/15/2007WO2006120034A8 Vaccine composition
11/15/2007WO2006098758A3 Compositions, methods and kits relating to cthrc1, a novel modulator of collagen matrix
11/15/2007WO2006078256A3 Polypeptides having xylanase activity and polynucleotides encoding same
11/15/2007WO2006076497A3 Osplation of pathogenic prions
11/15/2007WO2005120564A3 Vaccine compositions and methods
11/15/2007WO2005115454A3 Methods and compositions for cancer treatment relating to brca1 brct domain recognition of phosphorylated bach1
11/15/2007WO2004058988A3 Binding agents which inhibit myostatin
11/15/2007WO2003086313A3 Methods for lightening skin and hair
11/15/2007WO2003018754A3 Neural regeneration peptide and methods for their use in treatment of brain damage
11/15/2007WO2001075021A3 A novel polypeptide, glucose transport-associated human protein 10 and the polynucleotide encoding the polypeptide
11/15/2007WO2001055313A3 Nucleic acids, proteins, and antibodies
11/15/2007US20070266462 marker-assisted selection of a plant such as a maize plant, or plant part thereof, having an increased oil content and/or increased oleic acid content and/or an increased oleic acid/linoleic acid ratio, and for marker-assisted breeding of the high oil and/or high oleic acid trait
11/15/2007US20070266458 Isolated Polynucleotide Molecules Corresponding to Mutant and Wild-Type Alleles of the Maize D9 Gene and Methods of Use
11/15/2007US20070266453 comprising a plant transformation vector comprising a nucleotide sequence that encodes a DRO3 polypeptide; genetic engineering
11/15/2007US20070265436 Nucleotide sequences coding tumor-associated antigenic target polypeptide specific immunoglobulins for use in detection and prevention of cell proliferative disorders
11/15/2007US20070265431 PMMA binding peptides and methods of use
11/15/2007US20070265430 Made by inter-molecularly crosslinking the fluorescent protein such as a phycobiliprotein with itself; easier to purify; assay sensitivity; use in labeling and detection of biomolecules; crosslinker such as disuccinimidyl suberate
11/15/2007US20070265350 Method of identifying compounds useful to treat neuronal degenerative diseases
11/15/2007US20070265290 Male contraceptices; hormone sensitivity diseases; antidepressants; sexual disorders ; osteoporosis; alopecia; prostate cancer
11/15/2007US20070265218 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
11/15/2007US20070265205 nucleotide sequence that code an insecticidal protein for resistance against coleopteran pest the corn rootworm
11/15/2007US20070265202 Compounds That Modulate Trh Actions
11/15/2007US20070265201 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2
11/15/2007US20070265200 Glycol Linked Fgf-21 Compounds
11/15/2007US20070265199 comprising an A1 domain having a calcium binding site; hemophilia A; antihemophilia agents
11/15/2007US20070265198 Nucleic Acids and Polypeptides of C1 Bacteriophage and Uses Thereof
11/15/2007US20070265189 Insulin and igf-1 receptor agonists and antagonists
11/15/2007US20070265188 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
11/15/2007US20070264720 Polypropylene binding peptides and methods of use
11/15/2007US20070264715 Proteins Involved in Signal Transduction
11/15/2007US20070264714 Growth differentiation factor-9 regulatory sequences and uses therefor
11/15/2007US20070264711 Human pellino polypeptides
11/15/2007US20070264710 Process for Purifying Human Thrombopoietin with High Content of Sialic Acid
11/15/2007US20070264699 Method for cyrstallizing human GSK3 and novel crystal structure thereof
11/15/2007US20070264693 Hyphal growth in fungi
11/15/2007US20070264692 producing the hybrid proteins comprising a single polypeptide having a target protein with a ligand-dependent intein embedded in the sequence of target proteins; modulation of protein activity; molecular switches
11/15/2007US20070264690 Nucleic acids encoding lettuce big-vein viral proteins and utilization thereof
11/15/2007US20070264689 Ztnfr12 polypeptides and Ztnfr12 fusion proteins
11/15/2007US20070264686 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide; cancer treatment
11/15/2007US20070264685 Polynucleotides encoding cytokine receptor
11/15/2007US20070264681 Determining the transition between different phases of the cell cycle in mammalian cells; non-destructive
11/15/2007US20070264627 Retrovirus from the HIV group and its use
11/15/2007US20070264285 Compositions Comprising Cationic Microparticles And Hcv B1e2 Dna And Methods Of Use Thereof
11/15/2007US20070264284 Therapeutic, Prophylactic and Diagnostic Agents for Hepatitis B
11/15/2007US20070264283 Vaccine
11/15/2007US20070264279 Compositions and methods comprising a MAGE-b antigen
11/15/2007US20070264278 Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus
1 ... 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 ... 2916